Structure

Physi-Chem Properties

Molecular Weight:  278.12
Volume:  275.732
LogP:  1.928
LogD:  1.684
LogS:  -3.278
# Rotatable Bonds:  0
TPSA:  86.99
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.661
Synthetic Accessibility Score:  4.186
Fsp3:  0.533
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.013
MDCK Permeability:  1.516749762231484e-05
Pgp-inhibitor:  0.003
Pgp-substrate:  0.055
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.446

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.672
Plasma Protein Binding (PPB):  79.70451354980469%
Volume Distribution (VD):  0.892
Pgp-substrate:  23.818334579467773%

ADMET: Metabolism

CYP1A2-inhibitor:  0.371
CYP1A2-substrate:  0.647
CYP2C19-inhibitor:  0.032
CYP2C19-substrate:  0.699
CYP2C9-inhibitor:  0.034
CYP2C9-substrate:  0.435
CYP2D6-inhibitor:  0.06
CYP2D6-substrate:  0.193
CYP3A4-inhibitor:  0.333
CYP3A4-substrate:  0.255

ADMET: Excretion

Clearance (CL):  14.425
Half-life (T1/2):  0.194

ADMET: Toxicity

hERG Blockers:  0.031
Human Hepatotoxicity (H-HT):  0.4
Drug-inuced Liver Injury (DILI):  0.803
AMES Toxicity:  0.115
Rat Oral Acute Toxicity:  0.247
Maximum Recommended Daily Dose:  0.023
Skin Sensitization:  0.515
Carcinogencity:  0.617
Eye Corrosion:  0.008
Eye Irritation:  0.058
Respiratory Toxicity:  0.938

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC207346

Natural Product ID:  NPC207346
Common Name*:   Monodictysin B
IUPAC Name:   (1S,3S,4S,4aS,9aS)-1,4,8-trihydroxy-3,4a-dimethyl-2,3,4,9a-tetrahydro-1H-xanthen-9-one
Synonyms:   monodictysin B
Standard InCHIKey:  NFHLHXVIHBGFKO-XHOOZROUSA-N
Standard InCHI:  InChI=1S/C15H18O5/c1-7-6-9(17)12-13(18)11-8(16)4-3-5-10(11)20-15(12,2)14(7)19/h3-5,7,9,12,14,16-17,19H,6H2,1-2H3/t7-,9-,12+,14-,15-/m0/s1
SMILES:  C[C@H]1C[C@@H]([C@@H]2C(=O)c3c(cccc3O[C@]2(C)[C@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL223073
PubChem CID:   16114919
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5623 Monodictys putredinis Species n.a. Eukaryota n.a. n.a. n.a. PMID[17291041]
NPO5623 Monodictys putredinis Species n.a. Eukaryota n.a. n.a. n.a. PMID[18939864]
NPO5623 Monodictys putredinis Species n.a. Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT440 Individual Protein Quinone oxidoreductase Mus musculus IC50 > 50000.0 nM PMID[520743]
NPT30 Individual Protein Cyclooxygenase-1 Homo sapiens Inhibition < 50.0 % PMID[520743]
NPT441 Individual Protein Cytochrome P450 19A1 Homo sapiens Inhibition = 9.0 % PMID[520743]
NPT440 Individual Protein Quinone oxidoreductase Mus musculus Activity = 12.0 uM PMID[520743]
NPT2 Others Unspecified IC50 = 23300.0 nM PMID[520743]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC207346 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC46564
0.9655 High Similarity NPC191634
0.9597 High Similarity NPC164427
0.953 High Similarity NPC175192
0.9527 High Similarity NPC321363
0.9527 High Similarity NPC253904
0.9161 High Similarity NPC473961
0.9145 High Similarity NPC326910
0.906 High Similarity NPC71055
0.902 High Similarity NPC68727
0.9013 High Similarity NPC113608
0.9013 High Similarity NPC268992
0.9013 High Similarity NPC470338
0.9013 High Similarity NPC51824
0.9013 High Similarity NPC470337
0.8968 High Similarity NPC470339
0.8968 High Similarity NPC186113
0.8954 High Similarity NPC135522
0.8947 High Similarity NPC470675
0.8947 High Similarity NPC471677
0.8947 High Similarity NPC263384
0.8947 High Similarity NPC244577
0.8947 High Similarity NPC471676
0.8947 High Similarity NPC473131
0.8947 High Similarity NPC472420
0.8947 High Similarity NPC472422
0.8947 High Similarity NPC475076
0.8938 High Similarity NPC241874
0.8933 High Similarity NPC473133
0.8933 High Similarity NPC47388
0.8933 High Similarity NPC470670
0.8933 High Similarity NPC85773
0.8931 High Similarity NPC225419
0.891 High Similarity NPC471976
0.891 High Similarity NPC472055
0.8903 High Similarity NPC477833
0.8889 High Similarity NPC470340
0.8889 High Similarity NPC474843
0.8889 High Similarity NPC210597
0.8889 High Similarity NPC475790
0.8889 High Similarity NPC216035
0.8889 High Similarity NPC167903
0.8889 High Similarity NPC180944
0.8889 High Similarity NPC275878
0.8889 High Similarity NPC217149
0.8868 High Similarity NPC178173
0.8854 High Similarity NPC3629
0.8854 High Similarity NPC476929
0.8846 High Similarity NPC329091
0.8839 High Similarity NPC10754
0.8839 High Similarity NPC20530
0.8839 High Similarity NPC24640
0.8839 High Similarity NPC215917
0.8836 High Similarity NPC287068
0.8831 High Similarity NPC100134
0.8831 High Similarity NPC469405
0.8831 High Similarity NPC7989
0.8831 High Similarity NPC223701
0.8831 High Similarity NPC209760
0.8831 High Similarity NPC472583
0.8824 High Similarity NPC262039
0.8824 High Similarity NPC262038
0.8824 High Similarity NPC319910
0.8824 High Similarity NPC471229
0.8824 High Similarity NPC254412
0.8824 High Similarity NPC472636
0.8824 High Similarity NPC474023
0.8824 High Similarity NPC278476
0.8824 High Similarity NPC474021
0.882 High Similarity NPC251144
0.882 High Similarity NPC241387
0.8816 High Similarity NPC307052
0.8816 High Similarity NPC139966
0.8816 High Similarity NPC277032
0.8816 High Similarity NPC472628
0.8816 High Similarity NPC294502
0.8816 High Similarity NPC200221
0.8812 High Similarity NPC6588
0.8812 High Similarity NPC477154
0.8812 High Similarity NPC117854
0.8808 High Similarity NPC91902
0.8808 High Similarity NPC472627
0.8808 High Similarity NPC46941
0.8808 High Similarity NPC308200
0.8805 High Similarity NPC25361
0.88 High Similarity NPC311144
0.8797 High Similarity NPC472402
0.8797 High Similarity NPC474150
0.8797 High Similarity NPC215612
0.8797 High Similarity NPC474162
0.8797 High Similarity NPC472964
0.8792 High Similarity NPC130206
0.879 High Similarity NPC155302
0.879 High Similarity NPC161947
0.879 High Similarity NPC36217
0.879 High Similarity NPC470183
0.879 High Similarity NPC321399
0.879 High Similarity NPC470810
0.879 High Similarity NPC475784
0.879 High Similarity NPC472902
0.8784 High Similarity NPC145673
0.8782 High Similarity NPC245758
0.8782 High Similarity NPC475267
0.8782 High Similarity NPC181960
0.8782 High Similarity NPC472910
0.8782 High Similarity NPC48208
0.8782 High Similarity NPC299520
0.8782 High Similarity NPC96167
0.8782 High Similarity NPC472911
0.8782 High Similarity NPC474208
0.8782 High Similarity NPC162869
0.8782 High Similarity NPC469584
0.8782 High Similarity NPC472598
0.8782 High Similarity NPC472914
0.8782 High Similarity NPC474055
0.8782 High Similarity NPC222814
0.8782 High Similarity NPC27337
0.8782 High Similarity NPC474836
0.8782 High Similarity NPC472913
0.8782 High Similarity NPC129684
0.8782 High Similarity NPC156057
0.8774 High Similarity NPC259710
0.8774 High Similarity NPC217706
0.8774 High Similarity NPC477958
0.8774 High Similarity NPC207809
0.8774 High Similarity NPC304207
0.8774 High Similarity NPC476169
0.8774 High Similarity NPC31018
0.8774 High Similarity NPC37392
0.8774 High Similarity NPC48579
0.8774 High Similarity NPC472909
0.8774 High Similarity NPC255807
0.8774 High Similarity NPC471116
0.8774 High Similarity NPC67396
0.8774 High Similarity NPC321779
0.8766 High Similarity NPC281272
0.8766 High Similarity NPC56232
0.8766 High Similarity NPC138288
0.8766 High Similarity NPC35567
0.8766 High Similarity NPC473996
0.8766 High Similarity NPC150123
0.8766 High Similarity NPC10807
0.8766 High Similarity NPC243171
0.8766 High Similarity NPC75069
0.8766 High Similarity NPC171651
0.8766 High Similarity NPC161881
0.8766 High Similarity NPC244583
0.8765 High Similarity NPC472620
0.8765 High Similarity NPC118128
0.8758 High Similarity NPC29777
0.8758 High Similarity NPC202595
0.8758 High Similarity NPC267117
0.8758 High Similarity NPC105136
0.8758 High Similarity NPC471115
0.8758 High Similarity NPC225854
0.875 High Similarity NPC145467
0.875 High Similarity NPC43319
0.875 High Similarity NPC5537
0.875 High Similarity NPC469394
0.875 High Similarity NPC120593
0.875 High Similarity NPC10097
0.875 High Similarity NPC39195
0.875 High Similarity NPC170245
0.875 High Similarity NPC218569
0.8742 High Similarity NPC475985
0.8742 High Similarity NPC474302
0.8742 High Similarity NPC124038
0.8742 High Similarity NPC197168
0.8742 High Similarity NPC299011
0.8742 High Similarity NPC476931
0.8742 High Similarity NPC7483
0.8742 High Similarity NPC469758
0.8742 High Similarity NPC186686
0.8742 High Similarity NPC472629
0.8742 High Similarity NPC209278
0.8734 High Similarity NPC87431
0.8734 High Similarity NPC61010
0.8734 High Similarity NPC472632
0.8734 High Similarity NPC474186
0.8734 High Similarity NPC474038
0.8734 High Similarity NPC474187
0.8734 High Similarity NPC266314
0.8734 High Similarity NPC472634
0.8733 High Similarity NPC18886
0.8733 High Similarity NPC113770
0.8733 High Similarity NPC95751
0.8726 High Similarity NPC474290
0.8726 High Similarity NPC152904
0.8726 High Similarity NPC95936
0.8726 High Similarity NPC476242
0.8726 High Similarity NPC22192
0.8726 High Similarity NPC250214
0.8726 High Similarity NPC210459
0.8726 High Similarity NPC473990
0.8726 High Similarity NPC85121
0.8718 High Similarity NPC195796
0.8718 High Similarity NPC255106
0.8718 High Similarity NPC235165
0.8718 High Similarity NPC78492
0.8718 High Similarity NPC278778

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC207346 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.871 High Similarity NPD2393 Clinical (unspecified phase)
0.8645 High Similarity NPD1934 Approved
0.8516 High Similarity NPD4380 Phase 2
0.8471 Intermediate Similarity NPD2801 Approved
0.8456 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8456 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD1549 Phase 2
0.8344 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD6166 Phase 2
0.8323 Intermediate Similarity NPD5494 Approved
0.8313 Intermediate Similarity NPD7075 Discontinued
0.8313 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8312 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD5402 Approved
0.8247 Intermediate Similarity NPD1511 Approved
0.8239 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD6959 Discontinued
0.8155 Intermediate Similarity NPD6559 Discontinued
0.8144 Intermediate Similarity NPD7074 Phase 3
0.8141 Intermediate Similarity NPD1512 Approved
0.8137 Intermediate Similarity NPD3882 Suspended
0.8133 Intermediate Similarity NPD3818 Discontinued
0.8125 Intermediate Similarity NPD7819 Suspended
0.8089 Intermediate Similarity NPD5403 Approved
0.8084 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8084 Intermediate Similarity NPD5844 Phase 1
0.8084 Intermediate Similarity NPD7054 Approved
0.8079 Intermediate Similarity NPD1510 Phase 2
0.8072 Intermediate Similarity NPD7473 Discontinued
0.8063 Intermediate Similarity NPD6801 Discontinued
0.8036 Intermediate Similarity NPD7472 Approved
0.8026 Intermediate Similarity NPD6100 Approved
0.8026 Intermediate Similarity NPD1551 Phase 2
0.8026 Intermediate Similarity NPD2796 Approved
0.8026 Intermediate Similarity NPD6099 Approved
0.8025 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6232 Discontinued
0.8 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD6797 Phase 2
0.7963 Intermediate Similarity NPD3817 Phase 2
0.7962 Intermediate Similarity NPD5401 Approved
0.7962 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7953 Intermediate Similarity NPD8312 Approved
0.7953 Intermediate Similarity NPD8313 Approved
0.7947 Intermediate Similarity NPD1607 Approved
0.7941 Intermediate Similarity NPD7251 Discontinued
0.7937 Intermediate Similarity NPD6599 Discontinued
0.7935 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD1240 Approved
0.7922 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD6799 Approved
0.7895 Intermediate Similarity NPD7808 Phase 3
0.7888 Intermediate Similarity NPD7411 Suspended
0.7857 Intermediate Similarity NPD2346 Discontinued
0.7848 Intermediate Similarity NPD2533 Approved
0.7848 Intermediate Similarity NPD2532 Approved
0.7848 Intermediate Similarity NPD2534 Approved
0.7841 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD3750 Approved
0.7821 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7816 Intermediate Similarity NPD8434 Phase 2
0.7815 Intermediate Similarity NPD1613 Approved
0.7815 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7811 Intermediate Similarity NPD3751 Discontinued
0.7805 Intermediate Similarity NPD7768 Phase 2
0.7784 Intermediate Similarity NPD3787 Discontinued
0.7764 Intermediate Similarity NPD3226 Approved
0.7758 Intermediate Similarity NPD3749 Approved
0.7756 Intermediate Similarity NPD2800 Approved
0.7714 Intermediate Similarity NPD8150 Discontinued
0.7707 Intermediate Similarity NPD4628 Phase 3
0.7692 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD1465 Phase 2
0.7682 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD2935 Discontinued
0.7674 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7671 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD447 Suspended
0.7622 Intermediate Similarity NPD37 Approved
0.7616 Intermediate Similarity NPD4625 Phase 3
0.7613 Intermediate Similarity NPD2799 Discontinued
0.7605 Intermediate Similarity NPD6234 Discontinued
0.759 Intermediate Similarity NPD4967 Phase 2
0.759 Intermediate Similarity NPD4966 Approved
0.759 Intermediate Similarity NPD4965 Approved
0.7568 Intermediate Similarity NPD4749 Approved
0.7566 Intermediate Similarity NPD2313 Discontinued
0.7566 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD1610 Phase 2
0.755 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD4908 Phase 1
0.7541 Intermediate Similarity NPD6781 Approved
0.7541 Intermediate Similarity NPD6780 Approved
0.7541 Intermediate Similarity NPD6776 Approved
0.7541 Intermediate Similarity NPD6779 Approved
0.7541 Intermediate Similarity NPD6778 Approved
0.7541 Intermediate Similarity NPD6777 Approved
0.7541 Intermediate Similarity NPD6782 Approved
0.7516 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD1247 Approved
0.75 Intermediate Similarity NPD3748 Approved
0.75 Intermediate Similarity NPD7228 Approved
0.75 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD5760 Phase 2
0.747 Intermediate Similarity NPD5761 Phase 2
0.7468 Intermediate Similarity NPD2424 Discontinued
0.7468 Intermediate Similarity NPD943 Approved
0.7467 Intermediate Similarity NPD1470 Approved
0.7467 Intermediate Similarity NPD1203 Approved
0.7459 Intermediate Similarity NPD6823 Phase 2
0.7458 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD1201 Approved
0.743 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD920 Approved
0.7421 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD5124 Phase 1
0.7419 Intermediate Similarity NPD7435 Discontinued
0.7417 Intermediate Similarity NPD2798 Approved
0.741 Intermediate Similarity NPD6844 Discontinued
0.7389 Intermediate Similarity NPD7033 Discontinued
0.7386 Intermediate Similarity NPD3027 Phase 3
0.7383 Intermediate Similarity NPD9717 Approved
0.7378 Intermediate Similarity NPD1653 Approved
0.7372 Intermediate Similarity NPD6651 Approved
0.7368 Intermediate Similarity NPD5711 Approved
0.7368 Intermediate Similarity NPD5710 Approved
0.7363 Intermediate Similarity NPD4360 Phase 2
0.7363 Intermediate Similarity NPD4363 Phase 3
0.7351 Intermediate Similarity NPD2797 Approved
0.7349 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD3268 Approved
0.7338 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD7696 Phase 3
0.7326 Intermediate Similarity NPD7698 Approved
0.7326 Intermediate Similarity NPD7697 Approved
0.7326 Intermediate Similarity NPD3926 Phase 2
0.732 Intermediate Similarity NPD6832 Phase 2
0.7312 Intermediate Similarity NPD1652 Phase 2
0.731 Intermediate Similarity NPD7199 Phase 2
0.7308 Intermediate Similarity NPD230 Phase 1
0.7308 Intermediate Similarity NPD1933 Approved
0.7301 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD2344 Approved
0.7294 Intermediate Similarity NPD919 Approved
0.7287 Intermediate Similarity NPD7870 Phase 2
0.7287 Intermediate Similarity NPD7871 Phase 2
0.7284 Intermediate Similarity NPD3300 Phase 2
0.7278 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD4308 Phase 3
0.7273 Intermediate Similarity NPD5953 Discontinued
0.7268 Intermediate Similarity NPD6535 Approved
0.7268 Intermediate Similarity NPD6534 Approved
0.7263 Intermediate Similarity NPD7701 Phase 2
0.7258 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD7286 Phase 2
0.7255 Intermediate Similarity NPD2861 Phase 2
0.724 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.724 Intermediate Similarity NPD7801 Approved
0.724 Intermediate Similarity NPD7783 Phase 2
0.7239 Intermediate Similarity NPD7390 Discontinued
0.7226 Intermediate Similarity NPD411 Approved
0.7226 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD8151 Discontinued
0.7205 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD1243 Approved
0.72 Intermediate Similarity NPD1091 Approved
0.7197 Intermediate Similarity NPD6355 Discontinued
0.7197 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD4662 Approved
0.7195 Intermediate Similarity NPD4661 Approved
0.7195 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD5647 Approved
0.719 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD7874 Approved
0.7188 Intermediate Similarity NPD6004 Phase 3
0.7188 Intermediate Similarity NPD6005 Phase 3
0.7188 Intermediate Similarity NPD6002 Phase 3
0.7188 Intermediate Similarity NPD5762 Approved
0.7188 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD5763 Approved
0.7184 Intermediate Similarity NPD2403 Approved
0.7178 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD1548 Phase 1
0.716 Intermediate Similarity NPD8455 Phase 2
0.7152 Intermediate Similarity NPD6273 Approved
0.7152 Intermediate Similarity NPD1608 Approved
0.7151 Intermediate Similarity NPD7699 Phase 2
0.7151 Intermediate Similarity NPD7700 Phase 2
0.7135 Intermediate Similarity NPD7240 Approved
0.7134 Intermediate Similarity NPD4060 Phase 1
0.7126 Intermediate Similarity NPD2649 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data